GENE ONLINE|News &
Opinion
Blog

Orphan Drug Designation
The U.S. FDA Grants Orphan Drug Designation to NS-089/NCNP-02 for the Treatment of DMD
2023-08-17
South Korea Puts Everest Medicines’ Nefecon On Fast Track
2023-02-10
Algernon Wins FDA Orphan Drug Designation For Rare Lung Disease Candidate
2022-12-07
Everest’s Renal Drug Gets Placed On Fast Track For Approval In Taiwan And Korea
2022-11-28
BioCryst’s ALK-2 Inhibitor Granted FDA Orphan Drug Status For Rare Bone Disease
2022-09-01
Three Companies Received Orphan Drug Designations in One Day To Treat Rare Cancers
2022-06-20
Telix Granted FDA Orphan Drug Designation for Bone Marrow Conditioning Treatment
2022-03-29
GC Pharma’s Enzyme Replacement Therapy Wins Orphan Drug Designation from EMA
2021-11-02
R&D
BARDA Funds Development of Live Biotherapeutic Product Against C. difficile Infections
2020-10-05
Gilead Requests FDA to Rescind Remdesivir’s Orphan Drug Designation
2020-03-25
Gilead’s Remdesivir Wins FDA’s Orphan Drug Designation for COVID-19 Treatment
2020-03-24
Pfizer Collaborates with Vivet to Develop Gene Therapy for Wilson Disease
2019-03-29
LATEST
Revolutionary Technology Aims to Detect and Prevent Dementia and Mental Illness
2023-09-22
Connecting Global Biotech, Thailand’s Largest Biotech Event Takes Center Stage
2023-09-22
BIOHK2023: A place where biotechnology meets financial economics
2023-09-21
Connecting the Dots: TCELS Leads the Way for Thailand’s Life Sciences and Healthcare Innovations
2023-09-20
Deceptive Health Advice on TikTok Raises Concerns About Gynecologic Cancer Misinformation
2023-09-20
Dreams and Nightmares: the Mysterious Activities of the Brain During Deep Sleep
2023-09-20
GeneOnline’s Weekly News Highlights: Sept 11-Sept 15
2023-09-19
EVENT
2023-10-04
BioFuture 2023
New York city,USA
Scroll to Top